Ebaget D 10mg Tablet (Dapagliflozin) – Next-Generation SGLT2 Inhibitor for Type 2 Diabetes & Heart Health
Ebaget D 10mg Tablet (Dapagliflozin) – Next-Generation SGLT2 Inhibitor for Type 2 Diabetes & Heart Health
Ebaget D 10mg Tablet (Dapagliflozin) – Next-Generation SGLT2 Inhibitor for Type 2 Diabetes & Heart Health
Description
Ebaget D 10mg Tablet – Advanced Blood Sugar Control with Proven Heart & Kidney Protection
Ebaget D 10mg Tablet contains Dapagliflozin 10mg, a highly selective SGLT2 inhibitor that works by blocking glucose reabsorption in the kidneys, allowing excess sugar to be removed through urine. This once-daily tablet effectively lowers HbA1c, promotes healthy weight loss, reduces blood pressure, and delivers outstanding cardiovascular and renal protective benefits – including significant reduction in heart failure hospitalisation and slowing of chronic kidney disease progression in type 2 diabetes patients. Suitable for use alone or in combination with metformin, sulfonylureas, or insulin.


